Bristol-Myers: research deal with Boston Medical Center
(CercleFinance.com) - Bristol-Myers Squibb has finalised a multi-year research program with Boston Medical Center, a non-profit making medical center, to better understand immuno-oncology resistance.
The study will focus on mechanisms associated with lack of response to immuno-oncology therapies, with the goal of identifying prognostic and potentially predictive biomarkers in a variety of cancers.
In November, Bristol-Myers Squibb opened a R&D site near Boston focused on immuno-oncology resistance.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The study will focus on mechanisms associated with lack of response to immuno-oncology therapies, with the goal of identifying prognostic and potentially predictive biomarkers in a variety of cancers.
In November, Bristol-Myers Squibb opened a R&D site near Boston focused on immuno-oncology resistance.
Copyright (c) 2018 CercleFinance.com. All rights reserved.